News

Lymphoma Treatment Market to Surpass USD 14.66 Billion by 2032, Fueled by Immunotherapy Advancements and Emerging Market Expansion - SNS Insider
U.S. Market Leads with 74% Share in 2023 Valued at USD 2.71 Billion, Driven by Biotech Innovation, Favorable FDA Approvals, and Rising Chronic Disease Incidence.Austin, July 18, 2025 (GLOBE NEWSWIRE) ...
BioPharma Dive23h
Bristol Myers, Pfizer to offer Eliquis at a discount for some patients
The program is the latest example of pharmaceutical companies bypassing traditional drug distribution channels for people who ...